POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - MORTALITY DURING 2ND, 3RD, AND 4TH YEARS OF FOLLOW UP

被引:44
作者
COLINJONES, DG
LANGMAN, MJS
LAWSON, DH
VESSEY, MP
机构
[1] RADCLIFFE INFIRM, DEPT COMMUNITY MED & GEN PRACTICE, GIBSON LABS BLDG, OXFORD OX2 6HE, ENGLAND
[2] GLASGOW ROYAL INFIRM, DEPT CLIN PHARMACOL, GLASGOW G4 0SF, SCOTLAND
[3] UNIV NOTTINGHAM HOSP, DEPT THERAPEUT, NOTTINGHAM NG7 2UH, ENGLAND
[4] QUEEN ALEXANDRA HOSP, PORTSMOUTH, HANTS, ENGLAND
来源
BMJ-BRITISH MEDICAL JOURNAL | 1985年 / 291卷 / 6502期
关键词
D O I
10.1136/bmj.291.6502.1084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1084 / 1088
页数:5
相关论文
共 5 条
[1]  
BURGESS E, 1982, RENAL PHYSIOL BIOCH, V5, P27
[2]   POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 12 MONTH MORTALITY REPORT [J].
COLINJONES, DG ;
LANGMAN, MJS ;
LAWSON, DH ;
VESSEY, MP .
BMJ-BRITISH MEDICAL JOURNAL, 1983, 286 (6379) :1713-1716
[3]   CIMETIDINE AND GASTRIC-CANCER - PRELIMINARY-REPORT FROM POST-MARKETING SURVEILLANCE STUDY [J].
COLINJONES, DG ;
LANGMAN, MJS ;
LAWSON, DH ;
VESSEY, MP .
BRITISH MEDICAL JOURNAL, 1982, 285 (6351) :1311-1313
[4]  
JONES DGC, 1985, Q J MED, V54, P253
[5]   PROSPECTIVE-STUDY OF EARLY GASTRIC-CANCER [J].
TSUKUMA, H ;
MISHIMA, T ;
OSHIMA, A .
INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (04) :421-426